These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30671807)

  • 1. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
    Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
    Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
    Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
    Clin Transl Gastroenterol; 2018 Jun; 9(6):163. PubMed ID: 29915243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting Mac-2-Binding Protein Glycosylation Isomer (M2BPGi) for Diagnosing High-Risk Liver Fibrosis in Chronic Hepatitis B Patients: A Stepwise Diagnostic Analysis.
    Bestari MB; Haryono H; Wijaya MP; Girawan D; Agustanti N; Nugraha ES
    F1000Res; 2024; 13():280. PubMed ID: 39099607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
    Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF
    Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
    Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
    World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
    Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
    World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
    Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
    Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups.
    Nah EH; Cho S; Kim S; Kim HS; Cho HI
    J Clin Lab Anal; 2020 Aug; 34(8):e23316. PubMed ID: 32227396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.
    Noguchi R; Kaji K; Namisaki T; Moriya K; Kitade M; Takeda K; Kawaratani H; Okura Y; Aihara Y; Furukawa M; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Sep; 23(36):6705-6714. PubMed ID: 29085215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
    Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
    Su TH; Peng CY; Tseng TC; Yang HC; Liu CJ; Liu CH; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2020 Feb; 221(4):589-597. PubMed ID: 31574141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
    J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy.
    Murata A; Amano N; Sato S; Tsuzura H; Tomishima K; Sato S; Matsumoto K; Shimada Y; Iijima K; Genda T
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.
    Moon HW; Park M; Hur M; Kim H; Choe WH; Yun YM
    Ann Lab Med; 2018 Jul; 38(4):331-337. PubMed ID: 29611383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Bui HH; Nguyen ST; Phan ST; Nguyen KM; Nguyen CD
    Dig Dis Sci; 2023 Dec; 68(12):4407-4417. PubMed ID: 37861877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapy.
    Liu T; Sun Y; Zhou J; Yang F; Zou X; Wang L; Wu X; Chen Y; Piao H; Lu L; Jiang W; Xu Y; Feng B; Nan Y; Xie W; Chen G; Zheng H; Li H; Ding H; Liu H; Wang T; Ou X; Wu S; Kong Y; Wang P; Cong M; Zhang Y; You H; Jia J
    J Med Virol; 2019 Aug; 91(8):1499-1509. PubMed ID: 30905065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia.
    Ueno T; Kodama T; Noguchi Y; Saka R; Takama Y; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2018 Oct; 34(10):1065-1071. PubMed ID: 30128700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.
    Hsu YC; Jun T; Huang YT; Yeh ML; Lee CL; Ogawa S; Cho SH; Lin JT; Yu ML; Nguyen MH; Tanaka Y
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1128-1137. PubMed ID: 30306612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.